Sumana Narasimhan, MD

Dr Narasimhan completed her training in pediatric endocrinology at Cincinnati Children's Medical Center in 2005 and then worked at Rainbow Babies and Children's Hospital until 2015. Her main interests include general pediatric endocrinology, puberty, growth and hormone problems in survivors of childhood cancer.

Dr Narasimhan is an Associate Professor of Pediatrics at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University

Dr Narasimhan serves on the Senior Medical Staff Committee for Camp Ho Mita Koda and on the planning committee for Type 1 Nation, an annual summit for Diabetes organized by the JDRF in Northeast Ohio.

Dr Narasimhan is a member of the High-Five Cancer Survivor's Clinic. The High-Five Cancer Survivor's Clinic is a group of professionals who work hand in hand to meet the unique needs of our childhood cancer survivor patients and their families.

Education & Professional Highlights

Appointed
2015

Education & Fellowships

Fellowship - University of Cincinnati Hospital/Cincinnati Children's Hospital
Pediatric Endocrinology
Cincinnati, OH USA
2005

Residency - New York Medical College
Pediatrics
Valhalla, NY USA
1996

Residency - Lady Hardinge Medical College, Delhi University
Junior Anesthesia Resident
New Delhi, India
1993

Medical Education - Lady Hardinge Medical College, Delhi University
New Delhi, India
1990

Certifications

Pediatrics - Pediatric Endocrinology
Pediatrics

Specialty Interests

Hormone problems in survivors of childhood cancer, puberty issues, growth failure, diabetes, Quality Improvement in Health Care

Awards & Honors

US News and World Report/ Castle Conolly Top Doctor
Best Doctors 2009- present
Dr Kazi Uzair memorial award for Dedication and Commitment in the Care of Children: 1996

Research & Publications

See publications for Sumana Narasimhan, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/31/2023, Dr. Narasimhan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Coming to a Cleveland Clinic location?

Primary Location

Cleveland Clinic Main Campus

Additional Locations

Treatment & Services

Specialty in Diseases & Conditions

Insurance

Is Cleveland Clinic Part of Your Insurance?